S. Cedrés

4.4k citations
72 papers · 3.2k · 1 hit paper · h-index 25

Impact in

    • Occupational and environmental lung diseases
    • Pleural and Pulmonary Diseases
    • Lung Cancer Treatments and Mutations
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Medical Imaging and Pathology Studies
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies

Papers in

    • Occupational and environmental lung diseases 29
    • Lung Cancer Treatments and Mutations 19
    • Pleural and Pulmonary Diseases 11
    • Lung Cancer Diagnosis and Treatment 7
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
    • Cancer Immunotherapy and Biomarkers 12
    • Lung Cancer Research Studies 7

S. Cedrés

68 papers receiving 3.1k citations

S. Cedrés's Hit Papers

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial 2017 · 351 citations
3510+3+6Years since publication100200300

Peers

S. Cedrés
Comparison fields: 5 of 91
  • Pulmonary and Respiratory Medicine 1.7k
  • Oncology 1.2k
  • Biotechnology 187
  • Cancer Research 202
  • Immunology 274
Replace Alejandro Navarro with:
Alejandro Navarro Spain
Breelyn Ann Wilky United States
Sanatan Saraf United States
Seth M. Pollack United States
Neeta Somaiah United States
Geir Olav Hjortland Norway
Akin Atmaca Germany
Toshiyuki Kabuto Japan
Ravi Shridhar United States
Roopinder Gillmore United Kingdom
S. Cedrés relative to Alejandro Navarro Spain Alejandro Navarro's profile →
Citations per field
00.5×2×2.9×
Alejandro Navarro · 1×
Citations per year

Countries citing papers authored by S. Cedrés

Since Specialization
Citations

This map shows the geographic impact of S. Cedrés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cedrés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cedrés more than expected).

Fields of papers citing papers by S. Cedrés

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Cedrés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cedrés. The network helps show where S. Cedrés may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Cedrés, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Cedrés Line = papers co-authored together S. Cedrés links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
Hit paper breakdown →
2017351
2 2017337
3 2012237
4 2011174
5 2015171
6 2016150
7 2016144
8 2016137
9 2019131
10 2019118
11 2019107
12 200780
13 200871
14 202266
15 201663
16 201362
17 201260
18 201759
19 202255
20 202342

About S. Cedrés

S. Cedrés is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Hepatology and Biotechnology, having authored 72 papers that have together received 3.2k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (29 papers), Lung Cancer Treatments and Mutations (19 papers), Cancer Immunotherapy and Biomarkers (12 papers), Pleural and Pulmonary Diseases (11 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Diagnosis and Treatment (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.7k citations), Oncology (1.2k citations), Biotechnology (187 citations), Cancer Research (202 citations) and Immunology (274 citations). S. Cedrés has collaborated with scholars based in Spain, Belgium and Italy. Frequent co-authors include Enriqueta Felip, Pablo Martínez, Alejandro Navarro, Alex Martínez‐Martí, Davis Yuri Torrejon, Núria Pardo, Joachim G.J.V. Aerts, Esther Zamora, Aleix Prat and Anna K. Nowak. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer, Clinical & Translational Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact